CDKN1A and hepatocellular carcinoma: 1,25(OH)2D3 caused a dose-dependent decrease in the HCC growth rate. 1,25(OH)2D3 also decreased the mRNA expression and protein level of HDAC2 and increased the expression/protein level of p21(WAF1/Cip1).